Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib

Clinical trial NCT00320918 · TERMINATED

Trial details

NCT number: NCT00320918
Sponsor: University of New Mexico
Status: TERMINATED
Study type: OBSERVATIONAL

Cholangiocarcinoma

Start date: 2005-11-01
Primary completion: 2006-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.